BBlogFlow

Updated COVID-19, flu vaccines available in N.B. on Oct. 13 - CBC

·Oct 2, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

New BrunswickNew Brunswickers aged six months and older will be able to get updated COVID-19 and influenza vaccines for free, starting Oct. 13. RSV and pneumococcal vaccines also available as part of 2026-27 respiratory illness prevention campaignListen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. New Brunswickers can protect themselves and others by getting vaccinated, says Dr. Yves Léger, the province's chief medical officer of health. (Frank Augstein/The Associated Press)New Brunswickers aged six months and older will be able to get updated COVID-19 and influenza vaccines for free, starting Oct. 13. The province's chief medical officer of health strongly recommends both vaccines for people at risk of severe infection because of age or underlying health conditions. This includes people aged 65 and older, people who live in a long-term care home or other congregate settings, people with chronic health conditions and pregnant people.

This article is an excerpt. To read the full content, visit the original source. CBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·